Finer MH - Search Results

1

kat: a high-efficiency retroviral transduction system for primary human T lymphocytes.

Finer MH, Dull TJ, Qin L, Farson D, Roberts MR. Finer MH, et al. Blood. 1994 Jan 1;83(1):43-50. Blood. 1994. PMID: 8274751 Free article.

2

Large-scale manufacturing of safe and efficient retrovirus packaging lines for use in immunotherapy protocols.

Farson D, McGuinness R, Dull T, Limoli K, Lazar R, Jalali S, Reddy S, Pennathur-Das R, Broad D, Finer M. Farson D, et al. J Gene Med. 1999 May-Jun;1(3):195-209. doi: 10.1002/(SICI)1521-2254(199905/06)1:3<195::AID-JGM31>3.0.CO;2-#. J Gene Med. 1999. PMID: 10738568

3

Targeting of human immunodeficiency virus-infected cells by CD8+ T lymphocytes armed with universal T-cell receptors.

Roberts MR, Qin L, Zhang D, Smith DH, Tran AC, Dull TJ, Groopman JE, Capon DJ, Byrn RA, Finer MH. Roberts MR, et al. Among authors: finer mh. Blood. 1994 Nov 1;84(9):2878-89. Blood. 1994. PMID: 7949163 Free article.

4

Systemic T cell-independent tumor immunity after transplantation of universal receptor-modified bone marrow into SCID mice.

Hege KM, Cooke KS, Finer MH, Zsebo KM, Roberts MR. Hege KM, et al. Among authors: finer mh. J Exp Med. 1996 Dec 1;184(6):2261-9. doi: 10.1084/jem.184.6.2261. J Exp Med. 1996. PMID: 8976181 Free PMC article.

5

Persistent transgene expression in mouse liver following in vivo gene transfer with a delta E1/delta E4 adenovirus vector.

Wang Q, Greenburg G, Bunch D, Farson D, Finer MH. Wang Q, et al. Among authors: finer mh. Gene Ther. 1997 May;4(5):393-400. doi: 10.1038/sj.gt.3300404. Gene Ther. 1997. PMID: 9274715

6

Antigen-specific cytolysis by neutrophils and NK cells expressing chimeric immune receptors bearing zeta or gamma signaling domains.

Roberts MR, Cooke KS, Tran AC, Smith KA, Lin WY, Wang M, Dull TJ, Farson D, Zsebo KM, Finer MH. Roberts MR, et al. Among authors: finer mh. J Immunol. 1998 Jul 1;161(1):375-84. J Immunol. 1998. PMID: 9647246

7

A packaging cell line for propagation of recombinant adenovirus vectors containing two lethal gene-region deletions.

Wang Q, Jia XC, Finer MH. Wang Q, et al. Among authors: finer mh. Gene Ther. 1995 Dec;2(10):775-83. Gene Ther. 1995. PMID: 8750018

8

Hybrid yeast-bacteria cloning system used to capture and modify adenoviral and nonviral genomes.

Hokanson CA, Dora E, Donahue BA, Rivkin M, Finer M, Mendez MJ. Hokanson CA, et al. Hum Gene Ther. 2003 Mar 1;14(4):329-39. doi: 10.1089/104303403321208934. Hum Gene Ther. 2003. PMID: 12659674

9

Anti-tumor activity of human T cells expressing the CC49-zeta chimeric immune receptor.

McGuinness RP, Ge Y, Patel SD, Kashmiri SV, Lee HS, Hand PH, Schlom J, Finer MH, McArthur JG. McGuinness RP, et al. Among authors: finer mh. Hum Gene Ther. 1999 Jan 20;10(2):165-73. doi: 10.1089/10430349950018968. Hum Gene Ther. 1999. PMID: 10022542

10

Impact of chimeric immune receptor extracellular protein domains on T cell function.

Patel SD, Moskalenko M, Smith D, Maske B, Finer MH, McArthur JG. Patel SD, et al. Among authors: finer mh. Gene Ther. 1999 Mar;6(3):412-9. doi: 10.1038/sj.gt.3300831. Gene Ther. 1999. PMID: 10435091

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters